| Literature DB >> 32894809 |
Yukiko Nonoyama1,2, Mayumi Yamamoto3,4, Shino Oba5, Yukio Horikawa1,4, Chisato Nagata6, Daisuke Yabe1,4, Jun Takeda7.
Abstract
AIMS/Entities:
Keywords: Hypertriglyceridemia; Impaired glucose tolerance; Sex differences
Mesh:
Substances:
Year: 2020 PMID: 32894809 PMCID: PMC8089021 DOI: 10.1111/jdi.13398
Source DB: PubMed Journal: J Diabetes Investig ISSN: 2040-1116 Impact factor: 4.232
Characteristics of all the participants
| Total | Men | Women |
| |
|---|---|---|---|---|
|
|
|
| ||
| Age (years) | 58.5 ± 9.9 | 59.7 ± 10.2 | 57.6 ± 9.6 | 0.001 |
| BMI (kg/m2) | 22.9 ± 3.1 | 23.7 ± 3.1 | 22.2 ± 3.1 | <0.0001 |
| BMI ≥25 kg/m2 (%) | 23.2 | 30.2 | 17.9 | <0.0001 |
| Alcohol intake (g ethanol/day) | 15.6 ± 28.9 | 28.9 ± 37.7 | 5.7 ± 12.8 | <0.0001 |
| 0 g (non‐drinker) ( | 310 | 73 | 237 | <0.0001 |
| 0.1–19.9 g ( | 368 | 139 | 229 | |
| 20.0–39.9 g ( | 99 | 69 | 30 | |
|
| 121 | 103 | 18 | |
| TG (mg/dL) | 106.1 ± 60.5 | 121.8 ± 69.7 | 94.4 ± 49.6 | <0.0001 |
| LDL cholesterol (mg/dL) | 132.2 ± 31.0 | 130.7 ± 31.0 | 133.4 ± 31.0 | 0.2 |
| HDL cholesterol (mg/dL) | 63.2 ± 19.5 | 54.4 ± 16.5 | 69.8 ± 19.1 | <0.0001 |
| OGTT | ||||
| IFG or IGT or DM ( | 250 | 130 | 120 | <0.0001 |
| IFG or IGT or DM (%) | 27.8 | 34 | 23.4 | |
Values are presented as mean ± standard deviation for continuous variables, and number or percentages for categorical variables.
The P‐value was estimated using t‐tests for continuous variables, and χ2‐tests for categorical variables.
BMI, body mass index; DM, diabetes; HDL, high‐density lipoprotein. OGTT, oral glucose tolerance test; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; LDL, low‐density lipoprotein; TG, triglyceride.
Differences in the characteristics at each lipid profile
| TG | LDL | HDL | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Normal (<150 mg/dL) | High (≥150 mg/dL) |
| Normal (<140 mg/dL) | High (≥140 mg/dL) |
| Normal (≥40 mg/dL) | Low (<40 mg/dL) |
| |
| Men | |||||||||
|
| 290 | 94 | 226 | 158 | 304 | 76 | |||
| Age (years) | 60.0 ± 10.4 | 59.0 ± 9.7 | 0.41 | 60.3 ± 10.2 | 58.9 ± 10.2 | 0.18 | 59.8 ± 10.2 | 59.9 ± 10.3 | 0.9 |
| BMI (kg/m2) | 23.3 ± 2.9 | 24.9 ± 3.2 | <0.0001 | 23.3 ± 2.9 | 24.3 ± 3.1 | 0.001 | 23.3 ± 3.0 | 25.3 ± 2.9 | <0.0001 |
| BMI ≥25 kg/m2 (%) | 25.9 | 43.6 | 0.002 | 25.7 | 36.7 | 0.02 | 25.0 | 50.0 | <0.0001 |
| Alcohol intake (g ethanol/day) | 25.8 ± 34.5 | 38.4 ± 45.2 | 0.01 | 34.9 ± 42.0 | 20.3 ± 28.7 | <0.0001 | 29.9 ± 35.3 | 18.4 ± 30.2 | 0.005 |
| 0 g (non‐drinker) ( | 62 | 11 | 0.06 | 35 | 38 | 0.001 | 51 | 22 | 0.006 |
| 0.1–19.9 g ( | 108 | 31 | 71 | 68 | 107 | 32 | |||
| 20.0–39.9 g ( | 50 | 19 | 46 | 23 | 57 | 12 | |||
| ≥40 g ( | 70 | 33 | 74 | 29 | 89 | 10 | |||
| TG (mg/dL) | 92.7 ± 27.9 | 211.5 ± 82.4 | 120.2 ± 81.1 | 124.2 ± 48.9 | 0.55 | 108.0 ± 51.8 | 155.7 ± 55.8 | <0.0001 | |
| LDL cholesterol (mg/dL) | 130.5 ± 31.6 | 131.4 ± 29.3 | 0.81 | 110.3 ± 19.9 | 159.8 ± 18.3 | 130.6 ± 31.6 | 133.1 ± 27.6 | 0.53 | |
| HDL cholesterol (mg/dL) | 57.4 ± 16.2 | 44.7 ± 13.5 | <0.0001 | 56.2 ± 17.7 | 51.9 ± 14.2 | 0.009 | 59.5 ± 14.3 | 34.1 ± 4.5 | |
| HOMA‐IR | 1.42 ± 1.34 | 2.04 ± 1.44 | 0.0002 | 1.44 ± 1.33 | 1.75 ± 1.46 | 0.03 | 1.48 ± 1.42 | 1.91 ± 1.22 | 0.02 |
| HOMA‐β | 74.9 ± 70.6 | 92.7 ± 67.0 | 0.03 | 76.6 ± 79.4 | 83.2 ± 54.1 | 0.33 | 73.3 ± 68.2 | 96.2 ± 56.4 | 0.003 |
| FPG (mg/dL) | 94.1 ± 13.5 | 99.5 ± 17.2 | 0.007 | 95.0 ± 14.9 | 96.1 ± 14.3 | 0.45 | 95.3 ± 14.3 | 96.4 ± 16.1 | 0.55 |
| 2hPG (mg/dL) | 128.2 ± 49.1 | 150.5 ± 60.8 | 0.002 | 134.7 ± 56.4 | 131.8 ± 47.7 | 0.58 | 129.3 ± 51.3 | 147.3 ± 55.9 | 0.008 |
| HbA1c (%) | 5.71 ± 0.50 | 5.93 ± 0.62 | 0.002 | 5.70 ± 0.53 | 5.85 ± 0.54 | 0.008 | 5.74 ± 0.51 | 5.86 ± 0.61 | 0.11 |
| OGTT | |||||||||
| Normal ( | 206 | 46 | 0.0003 | 143 | 109 | 0.58 | 211 | 40 | 0.01 |
| IGT ( | 63 | 26 | 57 | 32 | 63 | 24 | |||
| IFG ( | 1 | 3 | 2 | 2 | 4 | 0 | |||
| DM ( | 20 | 17 | 23 | 14 | 24 | 12 | |||
| IFG or IGT or DM (%) | 29.0 | 50.0 | 0.0004 | 36.4 | 30.6 | 0.28 | 30.1 | 47.4 | 0.006 |
| Women | |||||||||
|
| 453 | 61 | 301 | 213 | 493 | 21 | |||
| Age (years) | 57.2 ± 9.7 | 60.0 ± 8.4 | 0.04 | 56.5 ± 10.6 | 59.1 ± 7.9 | 0.001 | 57.5 ± 9.6 | 58.3 ± 9.8 | 0.71 |
| BMI (kg/m2) | 22.0 ± 3.0 | 24.0 ± 2.9 | <0.0001 | 21.7 ± 2.9 | 23.0 ± 3.1 | <0.0001 | 22.2 ± 3.0 | 24.1 ± 3.0 | 0.003 |
| BMI ≥25 kg/m2 (%) | 15.7 | 34.4 | 0.001 | 13.3 | 24.4 | 0.002 | 16.9 | 42.9 | 0.006 |
| Alcohol intake (g ethanol/day) | 5.9 ± 13.1 | 3.6 ± 10.5 | 0.12 | 6.6 ± 14.2 | 4.4 ± 10.5 | 0.04 | 5.7 ± 13.0 | 4.0 ± 7.3 | 0.3 |
| 0 g (non‐drinker) ( | 211 | 26 | 0.03 | 134 | 103 | 0.16 | 228 | 9 | 0.6 |
| 0.1–19.9 g ( | 196 | 33 | 132 | 97 | 218 | 11 | |||
| 20.0–39.9 g ( | 30 | 0 | 21 | 9 | 29 | 1 | |||
| ≥40 g ( | 16 | 2 | 14 | 4 | 18 | 0 | |||
| TG (mg/dL) | 80.3 ± 28.3 | 198.7 ± 48.9 | 83.5 ± 47.6 | 109.8 ± 48.3 | <0.0001 | 92.1 ± 47.5 | 148.2 ± 65.2 | 0.0008 | |
| LDL cholesterol (mg/dL) | 131.6 ± 30.7 | 146.6 ± 30.0 | 0.0004 | 112.7 ± 18.9 | 162.5 ± 18.8 | 133.3 ± 31.0 | 136.2 ± 30.5 | 0.67 | |
| HDL cholesterol (mg/dL) | 71.9 ± 18.5 | 53.9 ± 15.6 | <0.0001 | 72.2 ± 20.3 | 66.3 ± 16.6 | 0.0003 | 71.2 ± 18.0 | 34.8 ± 2.9 | |
| HOMA‐IR | 1.26 ± 1.02 | 1.84 ± 1.58 | 0.007 | 1.25 ± 1.03 | 1.44 ± 1.21 | 0.06 | 1.29 ± 1.00 | 2.36 ± 2.47 | 0.06 |
| HOMA‐β | 76.7 ± 48.9 | 91.4 ± 43.7 | 0.03 | 78.7 ± 48.1 | 78.1 ± 49.2 | 0.88 | 77.6 ± 48.4 | 97.9 ± 47.9 | 0.06 |
| FPG (mg/dL) | 90.9 ± 17.6 | 95.6 ± 19.1 | 0.06 | 89.9 ± 15.3 | 93.8 ± 20.6 | 0.02 | 91.3 ± 17.7 | 96.0 ± 18.8 | 0.23 |
| 2hPG (mg/dL) | 113.8 ± 35.3 | 137.5 ± 48.5 | 0.0005 | 114.1 ± 35.5 | 120.1 ± 40.7 | 0.09 | 115.8 ± 36.8 | 136.3 ± 55.0 | 0.11 |
| HbA1c (%) | 5.71 ± 0.60 | 5.98 ± 0.95 | 0.04 | 5.67 ± 0.65 | 5.84 ± 0.66 | 0.004 | 5.74 ± 0.65 | 5.89 ± 0.84 | 0.31 |
| OGTT | |||||||||
| Normal ( | 356 | 36 | 0.0004 | 238 | 154 | 0.19 | 379 | 13 | 0.34 |
| IGT ( | 75 | 16 | 47 | 44 | 85 | 6 | |||
| IFG ( | 6 | 0 | 4 | 2 | 6 | 0 | |||
| DM ( | 14 | 9 | 10 | 13 | 21 | 2 | |||
| IFG or IGT or DM (%) | 21.1 | 41.0 | 0.001 | 20.4 | 27.7 | 0.06 | 22.8 | 38.1 | 0.12 |
Values are presented as mean ± standard deviation for continuous variables and number or percentages for categorical variables.
The P‐value was estimated using t‐tests for continuous variables and chi‐square tests for categorical variables.
2hPG, 2‐h post‐glucose; BMI, body mass index; DM, diabetes; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL, high‐density lipoprotein; HOMA‐IR, homeostasis model assessment‐insulin resistance; HOMA‐β, homeostasis model assessment‐beta cell function; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; LDL, low‐density lipoprotein; OGTT, oral glucose tolerance test; TG, triglyceride.
Figure 1Risks of impaired glucose tolerance according to the lipid profile. Adjusted odds ratios for impaired glucose tolerance with (a) hypertriglyceridemia, (b) increased serum low‐density lipoprotein (LDL) cholesterol level and (c) decreased serum high‐density lipoprotein (HDL) cholesterol level. The adjusted odds ratios of impaired glucose metabolism parameters (homeostasis model assessment of insulin resistance [HOMA‐IR], homeostasis model assessment of β‐cell function [HOMA‐β], fasting plasma glucose [FPG], 2‐h plasma glucose [2hPG], glycated hemoglobin [HbA1c], and oral glucose tolerance test [OGTT] results) were calculated using logistic regression analysis (adjusted for age, body mass index [BMI], and alcohol) for triglyceride (TG), LDL and HDL levels. 95% CI, 95% confidence interval; OR, odds ratio.
Figure 2Nutritional intake and serum triglyceride (TG; normal, serum TG level <150 mg/dL; high, serum TG level ≥150 mg/dL) levels with or without obesity in (a) men and (b) women. Total energy intake per day (kcal/day) is shown with bar charts, and the percentage intake of each nutrient (carbohydrate, protein, fat and alcohol per daily total energy intake) is shown as a number (%) in the graph. Student’s t‐test was used to compare two categories, whereas Dunnett’s test was used to compare four categories. *P < 0.05 by Dunnett’s tests. BMI, body mass index; NS, not significant.
Figure 3Risks of glycated hemoglobin elevation after 5 years at each lipid profile. Adjusted odds ratios (OR) of increase in glycated hemoglobin after 5 years were calculated using logistic regression analysis (adjusted for age, body mass index and alcohol intake) for triglyceride (TG), low‐density lipoprotein cholesterol (LDL‐cho) and high‐density lipoprotein cholesterol (HDL‐cho) levels. 95% CI, 95% confidence interval.